Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HUC3-637 | Experimental | Dorzolamide, Timolol |
|
| HUC3-637-R | Active Comparator | Dorzolamide, Timolol |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HUC3-637 | Drug | Ophthalmic solution instilled directly into the eye (topical ocular administration) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean change in diurnal IOP | 12 week |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Rang Lee | Contact | 07074926091 | rlee@huons.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kangbuk Samsung Hospital | Recruiting | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005902 | Glaucoma, Open-Angle |
| D009798 | Ocular Hypertension |
| ID | Term |
|---|---|
| D005901 | Glaucoma |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| HUC3-637-R | Drug | Ophthalmic solution instilled directly into the eye (topical ocular administration) |
|